Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 15667876)

Published in Urology on January 01, 2005

Authors

Benjamin K Yang1, Alfonso Crisci, Matthew D Young, Ari D Silverstein, Bercedis L Peterson, Philipp Dahm

Author Affiliations

1: Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Articles by these authors

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol (2002) 9.83

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ (2010) 7.15

From RNA-seq reads to differential expression results. Genome Biol (2010) 5.77

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest (2005) 5.30

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood (2002) 4.24

Low quality of evidence for robot-assisted laparoscopic prostatectomy: results of a systematic review of the published literature. Eur Urol (2010) 3.68

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B. J Clin Oncol (2006) 3.50

GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. Blood (2004) 3.28

Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. J Clin Oncol (2005) 3.05

GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02

Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol (2003) 2.77

Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. J Urol (2013) 2.76

Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol (2002) 2.74

Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ (2012) 2.69

Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer. J Clin Oncol (2007) 2.69

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol (2007) 2.42

Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer (2003) 2.39

Castration-resistant prostate cancer: AUA Guideline. J Urol (2013) 2.36

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol (2005) 2.34

Screening for prostate cancer. Cochrane Database Syst Rev (2013) 2.29

Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712. J Clin Oncol (2011) 2.26

Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805. Clin Cancer Res (2005) 2.19

A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol (2007) 2.16

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest (2002) 2.09

Long distance transport of ragweed pollen as a potential cause of allergy in central Italy. Ann Allergy Asthma Immunol (2006) 1.91

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2012) 1.90

Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol (2004) 1.82

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer. J Immunol (2005) 1.82

Active Mothers Postpartum: a randomized controlled weight-loss intervention trial. Am J Prev Med (2009) 1.71

Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol (2004) 1.70

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer (2002) 1.68

Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. Leuk Lymphoma (2009) 1.65

Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol (2003) 1.64

Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol (2012) 1.60

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011). Leuk Lymphoma (2012) 1.49

Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol (2008) 1.48

Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. Ann Surg Oncol (2006) 1.47

Evidence-based urology in practice: publication bias. BJU Int (2010) 1.44

Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med (2007) 1.44

Factors associated with the full publication of studies presented in abstract form at the annual meeting of the American Urological Association. J Urol (2007) 1.40

In vivo microwave-induced porcine kidney thermoablation: results and perspectives from a pilot study of a new probe. BJU Int (2010) 1.40

How to perform a literature search. J Urol (2008) 1.37

Active Mothers Postpartum (AMP): rationale, design, and baseline characteristics. J Womens Health (Larchmt) (2008) 1.27

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer (2011) 1.27

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. Clin Cancer Res (2006) 1.26

Reporting of harm in randomized controlled trials published in the urological literature. J Urol (2010) 1.25

Prenatal and postpartum smoking abstinence a partner-assisted approach. Am J Prev Med (2004) 1.23

How to use a systematic literature review and meta-analysis. J Urol (2008) 1.23

Management of nephropleural fistula after supracostal percutaneous nephrolithotomy. Urology (2004) 1.22

Adherence to nicotine replacement therapy among pregnant smokers. Nicotine Tob Res (2009) 1.21

Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer (2008) 1.20

Risk of spring frost to apple production under future climate scenarios: the role of phenological acclimation. Int J Biometeorol (2009) 1.18

The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review. BMJ (2011) 1.17

Heat-related mortality in the Florentine area (Italy) before and after the exceptional 2003 heat wave in Europe: an improved public health response? Int J Biometeorol (2011) 1.14

Reversal of tumor-mediated immunosuppression. Clin Cancer Res (2007) 1.13

Evidence based clinical practice: a primer for urologists. J Urol (2007) 1.13

The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prev Res (Phila) (2009) 1.13

Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer. Clin Cancer Res (2012) 1.11

Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring. J Urol (2004) 1.11

Relationships between weather and myocardial infarction: a biometeorological approach. Int J Cardiol (2005) 1.09

Re: comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis: s. P. Kim, R. H. Thompson, s. A. Boorjian, C. J. Weight, L. C. Han, m. H. Murad, N. D. Shippee, p. J. Erwin, B. A. Costello, g. K. Chow and B. C. Leibovich j urol 2012; 188: 51-57. J Urol (2012) 1.09

Predictors of clinical outcomes in the laparoscopic management of adnexal masses. Obstet Gynecol (2003) 1.06

Predictors of citations in the urological literature. BJU Int (2011) 1.05

Assessment of stricture formation with the ureteral access sheath. Urology (2003) 1.05

Assessing and presenting summaries of evidence in Cochrane Reviews. Syst Rev (2013) 1.05

Kids and adults now! Defeat Obesity (KAN-DO): rationale, design and baseline characteristics. Contemp Clin Trials (2011) 1.04

Relationship between work-related accidents and hot weather conditions in Tuscany (central Italy). Ind Health (2006) 1.04

History of evidence-based medicine. Indian J Urol (2011) 1.04

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study. Cancer Chemother Pharmacol (2002) 1.02

A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database. Urology (2007) 1.02

Adrenal myelolipoma associated with adenoma. Int J Urol (2004) 1.02

Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol (2002) 1.02

Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. Nicotine Tob Res (2006) 1.01

Techniques to maximize flexible ureteroscope longevity. Urology (2002) 1.01

Time- and Spectral-resolved two-photon imaging of healthy bladder mucosa and carcinoma in situ. Opt Express (2010) 1.01

Evidence-based medicine: a survey of American Urological Association members. J Urol (2006) 1.00

No difference in response rate to a mailed survey among prostate cancer survivors using conditional versus unconditional incentives. Cancer Epidemiol Biomarkers Prev (2004) 0.99

Predictors of postpartum weight change among overweight and obese women: results from the Active Mothers Postpartum study. J Womens Health (Larchmt) (2011) 0.99

Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res (2002) 0.98

The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer (2010) 0.97

Assessment of the methodological quality of systematic reviews published in the urological literature from 1998 to 2008. J Urol (2010) 0.97

A synoptic approach to weather conditions discloses a relationship with ambulatory blood pressure in hypertensives. Am J Hypertens (2008) 0.96

Percutaneous nephrolithotomy among patients with renal anomalies: patient characteristics and outcomes; a subgroup analysis of the clinical research office of the endourological society global percutaneous nephrolithotomy study. J Endourol (2011) 0.96

The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index. Eur Urol (2005) 0.96

Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing. Clin Cancer Res (2011) 0.96

Relationship between body mass index and prostate cancer screening in the United States. J Urol (2007) 0.96

Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings. J Urol (2009) 0.96

Winter air-mass-based synoptic climatological approach and hospital admissions for myocardial infarction in Florence, Italy. Environ Res (2006) 0.95

Supplement use among men with prostate cancer. Urology (2005) 0.95

Evaluating the evidence: the methodological and reporting quality of comparative observational studies of surgical interventions in urological publications. BJU Int (2008) 0.95

Innovative approaches helpful to enhance knowledge on weather-related stroke events over a wide geographical area and a large population. Stroke (2011) 0.94

Robot-assisted excision of seminal vesicle cyst associated with ipsilateral renal agenesis. J Endourol (2007) 0.94

Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials. Trials (2009) 0.94

Clinical research and statistical methods in the urology literature. J Urol (2005) 0.93